New Delhi:After the Maggie controversy,more than 2,100 import batches of ‘made in India’ productshave been banned by the US food and drug regulator in the past one year. Most of the products were by leading companies such as Hindustan Unilever, Britannia, Nestle India, Haldiram, Heinz India and MTR Foods. The reasons for rejection vary from minor labelling issues to products manufactured in unhygienic conditions to pesticides being above permissible limits, according to data put out by the US Food and Drug Administration (USFDA) on its website.
Several companies argued that the bulk of products were shipped without their knowledge by unauthorised third-party traders.”Instances of product rejections could be either due to improper storage and distribution done by unauthorised exporters. In case our official export products are rejected, we always re-test them at FDA-approved labs,” said AK Tyagi, director at Haldiram Manufacturing Ltd. Tyagi added that the US FDA regularly inspected its facilities in India and its products conform to global safety norms.
Britannia said it exports to the US only out of USFDA-registered factories in India and meets all product and labelling standards. The products that were rejected by the USFDA were not shipped directly by the company.Similarly, both Hindustan Unilever and Nestle India said the products that were banned were not exported by them.